ストックスクリーナーアプリを入手
0.4107
5.17%
-0.0224
プレマーケット:
.41
-0.0007
-0.17%
前日終値:
$0.4331
開ける：
$0.44
24時間の取引高:
3.46M
Relative Volume:
0.60
時価総額：
$62.99M
収益：
-
当期純損益:
$-56.85M
株価収益率:
-0.2634
EPS:
-1.559
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.67%
1か月 パフォーマンス:
-79.47%
6か月 パフォーマンス:
-58.26%
1年 パフォーマンス:
-72.25%
1日の値動き範囲:
$0.4071
$0.44
1週間の範囲:
$0.3901
$0.4953
52週間の値動き範囲:
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Compare GUTS vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.4107 | 66.43M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | 開始されました | H.C. Wainwright | Buy |
| 2025-08-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-02-28 | 開始されました | Evercore ISI | Outperform |
| 2024-02-27 | 開始されました | BofA Securities | Buy |
| 2024-02-27 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Fractyl Health Inc (GUTS) 最新ニュース
Insider Sell: What is the dividend yield of Fractyl Health IncJuly 2025 Final Week & AI Driven Price Predictions - baoquankhu1.vn
Risk Off: How correlated is Fractyl Health Inc to the S P500Quarterly Trade Report & Community Consensus Trade Signals - baoquankhu1.vn
Aug Technicals: Does Fractyl Health Inc have pricing powerJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Even endpoint hits don’t spare shares in three weight-loss updates - BioCentury
Why Fractyl Health Inc. stock remains a top recommendationJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
Market Trends: Is Fractyl Health Inc benefiting from interest rate changesJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - baoquankhu1.vn
Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
Fractyl Health plummets on data for Revita for weight loss maintenance - MSN
Why did GUTS stock plummet today despite positive gut therapy midterm study? - MSN
Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA PlanHas The Bull Case Changed? - Sahm
Fractyl Health Shares Fall After Morgan Stanley Downgrade - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fractyl Health, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your Rights – GUTS - marketscreener.com
Institutional Owners May Take Dramatic Actions as Fractyl Health, Inc.'s (NASDAQ:GUTS) Recent 72% Drop Adds to One-year Losses - 富途牛牛
Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics - Yahoo Finance
Revita treatment shows promise for weight maintenance after GLP-1 use By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results By Investing.com - Investing.com South Africa
Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results - Investing.com India
What if Oprah Knew About Fractyl Health? - MedCity News
Why Is Fractyl Health Stock Tumbling Today?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health's Revita reduces post-GLP-1 weight regain by ~70% - TechTarget
Crude Oil Surges 3%; Caterpillar Shares Gain After Q4 Results - Benzinga
Fractyl Health announces compelling 6-month randomized Remain-1 midpoint data showing durable weight maintenance with Revita after GLP-1 discontinuation - marketscreener.com
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Fractyl’s Revita reduces post-GLP-1 weight regain 70% - BioWorld MedTech
GUTS: Revita cut post-GLP-1 weight regain by 70% in high-risk patients at six months, with strong safety - TradingView
US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings - Benzinga
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? - Stocktwits
GUTS: Revita shows robust six-month weight maintenance post-GLP-1, supporting pivotal study success - TradingView
Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance - TipRanks
Will Fractyl Health Inc. outperform during market ralliesQuarterly Profit Summary & Safe Entry Momentum Stock Tips - mfd.ru
Fractyl Health's Revita Demonstrates Durable Weight Maintenance; Shares Fall Despite Positive Data - Nasdaq
Revita treatment shows promise for weight maintenance after GLP-1 use - Investing.com Canada
Fractyl Health Announces 6-Month REMAIN-1 Midpoint Data - TradingView
Revita trial cuts post-GLP-1 weight regain at Fractyl Health (GUTS) - stocktitan.net
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance By Investing.com - Investing.com South Africa
Fractyl Health stock falls after midpoint data on GLP-1 weight maintenance - Investing.com Canada
Fractyl Health Announces Compelling 6-Month Randomized Remain-1 Midpoint Data Showing Durable Weight Maintenance With Revita® After Glp-1 Discontinuation - TradingView
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - The Manila Times
GUTS: Revita shows sustained weight maintenance and safety post-GLP-1, with key 2026 milestones ahead - TradingView
Fractyl Health Announces Compelling 6-Month Randomized - GlobeNewswire
Biotech Alert: Searches spiking for these stocks today - TipRanks
HC Wainwright Forecasts Fractyl Health FY2030 Earnings - MarketBeat
U.S. Bio Firms Develop Single-Injection Gene Therapies to Cure Obesity - 조선일보
The next frontier in weight-loss drugs: one-time gene therapy - The Washington Post
Volume Summary: Is Fractyl Health Inc undervalued by DCF analysis2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 24.0% - MarketBeat
What is the PEG ratio of Fractyl Health Inc.Quarterly Trade Review & Consistent Return Investment Signals - bollywoodhelpline.com
Earnings Risk: What is the dividend yield of Fractyl Health IncTrade Signal Summary & Community Supported Trade Ideas - baoquankhu1.vn
Fractyl Health Inc (GUTS) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):